Baker Bros. Advisors LP Rocket Pharmaceuticals, Inc. Transaction History
Baker Bros. Advisors LP
- $9.86 Billion
- Q2 2025
A detailed history of Baker Bros. Advisors LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 552,079 shares of RCKT stock, worth $2.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
552,079
Previous 1,097,079
49.68%
Holding current value
$2.21 Million
Previous $7.32 Million
81.52%
% of portfolio
0.01%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding RCKT
# of Institutions
219Shares Held
98.4MCall Options Held
608KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$70.8 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$33.5 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$24.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$24.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$19.3 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $303M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...